TABLE 2.
Study | Patient | Implants | SCs | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Author | Year | Design | Setting | Initial (n) | End of follow‐up (n) | Drop‐out (n) | Drop‐out (%) | Mean age (y) | Initial (n) | Failed (n) | Initial (n) | SCs anterior (n) | SCs posterior (n) | End of follow‐up (n) | Drop‐out (n) | Screw‐Retained (n) | Cemented (n) |
Veneered Zr SCs | |||||||||||||||||
Meijndert et al. | 2020 | Pro | U | 60 | 50 | 10 | 17 | 36,9 | 60 | 0 | 60 | 54 | 6 | 10 | 33 | 27 | |
Rammelsberg et al. Group A | 2020 | Pro | U | 404 | nr | nr | 23 | 57,8 | 92 | 3 | 92 | nr | nr | nr | nr | nr | nr |
Wittneben et al. Group B | 2020 | RCT | U | 20 | 20 | 0 | 0 | nr | 20 | 0 | 20 | nr | nr | 20 | nr | 20 | 0 |
Cantner et al. | 2019 | Pro | PP | 118 | 105 | 13 | 11 | nr | 114 | 0 | 114 | 0 | 114 | nr | nr | 53 | 61 |
Furze et al. | 2019 | RCT | PP | 19 | 19 | 0 | 0 | 53,4 | 19 | 0 | 19 | 19 | 0 | 19 | 0 | 19 | 0 |
Guljé et al. | 2019a | RCT | U & PP | 38 | 36 | 2 | 5 | 49 | 41 | 1AF | 41 | 0 | 41 | 39 | nr | 0 | 41 |
Guljé et al. | 2019b | Pro | U & PP | 21 | 21 | 0 | 0 | 57,3 | 31 | 0 | 31 | 0 | 31 | 31 | 0 | 0 | 31 |
Heierle et al. Group A | 2019 | RCT | U | 34 | 27 | 7 | 21 | nr | 17 | nr | 17 | 17 | 0 | 13 | nr | 17 | 0 |
Kraus et al. Group A | 2019 | RCT | U | 44 | 40 | 4 | 9 | 51,4 | 24 | 0 | 24 | 7 | 17 | 20 | 2 | 24 | 0 |
Ma et al. | 2019 | Pro | U | 27 | 16 | 9 | 33 | 47,1 | 28 | 2BF | 26 | nr | nr | nr | 9 | 26 | 0 |
Weigl et al. | 2019 | RCT | U | 21 | 21 | 0 | 0 | 44 | 21 | 0 | 21 | 0 | 21 | 21 | nr | 0 | 21 |
Amorfini et al. | 2018 | RCT | U & PP | 40 | 30 | 10 | 25 | 48 | 32 | 0 | 32 | 17 | 15 | 30 | 2 | 16 | 16 |
Bösch et al. | 2018 | RCT | PP | 29 | 29 | 0 | 0 | 43,7 | 13 | 0 | 13 | 3 | 9 | 12 | 0 | 13 | 0 |
Bömicke et al. | 2017 | RCT | U | 38 | 35 | 3 | 8 | 52,9 | 38 | 1BF | 38 | 0 | 38 | nr | 3 | 0 | 38 |
Güncü et al. | 2016 | Pro | U & PP | 24 | 24 | 0 | 0 | 44,1 | 23 | 0 | 24 | 0 | 24 | 24 | 0 | 0 | 24 |
Paolantoni et al. Gruppe B | 2016 | RCT | U | 65 | 65 | 0 | 0 | 53 | 45 | 0 | 45 | 45 | 0 | 45 | 0 | 45 | 29 |
Kolgeci et al. | 2014 | Pro | PP | 137 | 127 | 10 | 7 | 62.5 | 289 | 2 | 120 | nr | nr | 115 | nr | 108 | 12 |
Nothdurft et al. | 2014 | Pro | U | 24 | 23 | 1 | 4 | nr | 39 | 0 | 39 | 0 | 39 | 37 | 2 | 0 | 39 |
Hosseini et al. | 2013 | Pro | U | 59 | 57 | 2 | 3 | 27,9 | 61 | 0 | 61 | 49 | 12 | nr | 2 | 0 | 61 |
Lops et al. | 2013 | Pro | U | 85 | 81 | 4 | 5 | 54 | 38 | 0 | 38 | na | 37 | 37 | 2 | 0 | 38 |
Pieri et al. | 2013 | Pro | U | 29 | 29 | 0 | 0 | 45,3 | 29 | 0 | 29 | 29 | 0 | 29 | 0 | 0 | 29 |
Zembic et al. | 2013 | RCT | U | 22 | 18 | 4 | 18 | 41,3 | 12 | 1AF | 12 | 2 | 10 | nr | nr | 2 | 10 |
Vandeweghe et al. | 2012 | Pro | U | 14 | 14 | 0 | 0 | 55 | 15 | 0 | 15 | 5 | 10 | 15 | 0 | 15 | 0 |
Hosseini et al. | 2011 | RCT | U | 36 | 36 | 0 | 0 | 28,1 | 38 | 0 | 38 | 0 | 38 | 38 | 0 | 0 | 38 |
Monoithic Zr SCs | |||||||||||||||||
Mühlemann et al. | 2020 | RCT | U | 39 | 33 | 0 | 6 | 57,7 | 39 | 1AF | 39 | 0 | 39 | 38 | 0 | 39 | 0 |
Rammelsberg et al. Group B | 2020 | Pro | U | 404 | nr | nr | 23 | 57,8 | 42 | 1 | 42 | nr | nr | nr | nr | nr | nr |
Rammelsberg et al. Group C | 2020 | Pro | U | 404 | nr | nr | 23 | 57,8 | 152 | 0 | 152 | nr | nr | nr | nr | nr | nr |
Cheng et al. | 2019 | RCT | U | 20 | 20 | 0 | 0 | 48,1 | 36 | 1 | 36 | nr | nr | 36 | 0 | 11 | 25 |
Koenig et al. | 2019 | Pro | U | 47 | 44 | 3 | 0 | 54,3 | 48 | 2 | 48 | 0 | 48 | nr | nr | 44 | 4 |
Pol et al. | 2019 | Pro | U | 30 | 30 | 0 | 0 | 53 | 30 | 0 | 30 | 0 | 30 | 30 | 0 | 30 | 0 |
Weigl et al. | 2019 | RCT | U | 22 | 22 | 0 | 0 | 43 | 22 | 0 | 22 | 0 | 22 | 22 | 0 | 22 | 0 |
Mangano & Veronesi | 2018 | RCT | PP | 25 | 25 | 0 | 0 | 51,6 | 25 | 0 | 25 | 0 | 25 | 24 | 0 | 0 | 25 |
Veneered LiSi2 and Leucite SCs | |||||||||||||||||
Heierle et al. Group B | 2019 | RCT | U | 34 | 27 | 7 | 21 | nr | 17 | nr | 17 | 17 | 0 | 14 | nr | 0 | 17 |
Kraus et al. Group B | 2019 | RCT | U | 44 | 40 | 4 | 9 | 51,4 | 20 | 1AF | 20 | 4 | 16 | 16 | 2 | 0 | 20 |
Laass et al. | 2019 | RCT | U | 20 | 16 | 4 | 20 | 46 | 20 | 0 | 20 | 10 | 10 | 16 | nr | 0 | 20 |
Teichmann et al. | 2017 | Pro | U | 14 | 12 | 2 | 14 | 40,7 | 32 | 0 | 22 | 10 | 7 | 17 | 15 | 0 | 17 |
Zembic et al. | 2015 | Pro | U | 27 | 16 | 11 | 41 | nr | 54 | 0 | 54 | 24 | 7 | 31 | 23 | 31 | 0 |
Monolithic LiSi2 and Leucite SCs | |||||||||||||||||
Gierthmuehlen et al. | 2020 | Pro | U | 28 | 27 | 1 | 4 | 49,9 | 45 | 0 | 45 | 0 | 45 | 44 | 1 | 45 | 0 |
Koller et al. | 2020 | Pro | U | 22 | 22 | 0 | 0 | 46 | 15 | 1AF | 15 | 2 | 13 | 14 | 0 | 0 | 15 |
Rammelsberg et al. Group D | 2020 | Pro | U | 404 | nr | nr | 23 | 57,8 | 3 | 2 | 3 | nr | nr | nr | nr | nr | nr |
Rammelsberg et al. Group E | 2020 | Pro | U | 404 | nr | nr | 23 | 57,8 | 7 | 0 | 7 | nr | nr | nr | nr | nr | nr |
Wittneben et al. Group A | 2020 | RCT | U | 20 | 19 | 1 | 5 | nr | 20 | 0 | 20 | nr | nr | 18 | nr | 0 | 20 |
Cömlekoglu et al. | 2019 | RCT | U | 16 | 16 | 0 | 0 | 36.1 | 32 | 0 | 32 | 32 | 0 | nr | nr | 0 | 32 |
Linkevicius et al. | 2018 | Pro | PP | 56 | 55 | 1 | 2 | 47,3 | 56 | 0 | 56 | 0 | 55 | 55 | 1 | 56 | 0 |
Joda et al. | 2017 | Pro | U | 44 | 44 | 0 | 0 | 58,1 | 50 | 0 | 50 | 0 | 50 | 50 | 0 | 50 | 0 |
Cooper et al. | 2016 | Pro | U & PP | 141 | 110 | 31 | 22 | 45 | 128 | 2 | 128 | 95 | 33 | 128 | 0 | 0 | 128 |
Paolantoni Gruppe A et al. | 2016 | RCT | U | 65 | 65 | 0 | 0 | 53 | 29 | 0 | 29 | 29 | 0 | 29 | 0 | 0 | 29 |
Peron & Romanos et al. | 2016 | Pro | PP | 25 | 25 | 0 | 0 | 43,3 | 26 | 0 | 26 | 5 | 21 | 26 | 0 | 24 | 2 |
Guarnieri | 2015 | Pro | PP | 21 | 21 | 0 | 0 | 34 | 21 | 1BF | 20 | 20 | 0 | 20 | 0 | nr | nr |
Vanlioglu et al. | 2012 | Pro | U | 12 | 12 | 0 | 0 | 33,2 | 23 | 0 | 23 | 23 | 0 | 23 | 0 | 0 | 23 |
Canullo et al. | 2007 | Pro | PP | 25 | 25 | 0 | 0 | 52,3 | 30 | 0 | 30 | 16 | 14 | 30 | 0 | 0 | 30 |
Vennered Al2O3 | |||||||||||||||||
Fenner et al. | 2016 | Pro | U | 36 | 29 | 7 | 19 | 48 | 13 | nr | 17 | nr | nr | 13 | 4 | nr | nr |
Ormianer et al. | 2006 | Pro | PP | 18 | 18 | 0 | 0 | 42,2 | 22 | 0 | 22 | 14 | 8 | 22 | 0 | 0 | 22 |
Henrikson & Jamt | 2003 | Pro | U | 20 | 19 | 1 | 5 | 29 | 24 | 0 | 24 | 24 | 0 | 23 | 1 | 11 | 13 |
Andersson et al. | 1998 | Pro | U | 57 | 53 | 4 | 7 | 31,8 | 55 | 0 | 65 | nr | nr | 55 | 5 | 0 | 62 |
RNC SCs | |||||||||||||||||
Augustín‐Pandero et al. | 2020 | RCT | U | 42 | 32 | 10 | 24 | nr | 25 | 1 | 25 | 0 | 25 | nr | 0 | 25 | |
Schepke et al. | 2016 | RCT | U | 50 | 50 | 0 | 0 | 47,7 | 50 | 0 | 50 | 0 | 50 | 7 | 0 | 0 | 50 |
Abbreviations: AF, failed implant after loading; BF, failed implant before loading; nr, not reported; na, not applicable; Pro, prospective clinical study; PP, private practice setting; RCT, randomized controlled trial; U, university setting.